What's Happening With Bellerophon Therapeutics Stock Today?
What's Happening With Bellerophon Therapeutics Stock Today?
Bellerophon Therapeutics (NASDAQ:BLPH) stock is driving after receiving a delisting notice.
Bellerophon Therape 納斯達克股票代碼：BLPH）股票在收到退市通知後正在上漲。
The Listing Qualifications Department for the Nasdaq Exchange has decided to delist shares of Bellerophon stock on 28 July unless the company timely requests a hearing before a Nasdaq Hearings Panel to address the deficiencies and present a plan to regain compliance.
納斯達克交易所上市資格部門決定 除名 7月28日Bellerophon股票的股票，除非該公司及時要求在納斯達克聽證會小組舉行聽證會，以解決缺陷並提出恢復合規的計劃。
The company plans to timely request a hearing before the Panel, which request will stay any further delisting action by the Staff pending the outcome of the hearing and the expiration of any extension that the Panel may grant.
該公司計劃及時要求小組舉行聽證會，在聽證會結果出來以及小組可能批准的任何延期到期之前，該聽證會將暫停工作人員採取任何進一步的除名行動。
The company's common stock will remain listed and eligible for trading on Nasdaq, at least pending the ultimate conclusion of the hearing process.
該公司的普通股將繼續在納斯達克上市並有資格在納斯達克交易，至少在聽證程序最終結束之前是如此。
The delisting notice comes after the company laid off workers and announced plans to explore strategic alternatives. According to the Nasdaq Listing Qualifications Department, this has Bellerophon Therapeutics acting as a public shell company, which makes it ineligible to remain listed.
退市通知是在該公司裁員並宣佈計劃探索戰略替代方案之後發佈的。根據納斯達克上市資格部門的說法，這使Bellerophon Therapeutics充當了上市空殼公司，這使其沒有資格繼續上市。
Price Action: BLPH shares are down 38% at $0.44 on the last check Tuesday.
價格走勢： 週二的最後一張支票顯示，BLPH股價下跌了38％，至0.44美元。
譯文內容由第三人軟體翻譯。